This brand name is authorized in France
The drug BICIRKAN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Dry extract of Ruscus aculeatus
UNII 5KEZ82GMGU - RUSCUS ACULEATUS WHOLE
|
|
|
|
2
Hesperidin
UNII 4T2GVA922X - HESPERIDIN METHYLCHALCONE
|
|
|
|
3
Vitamin C
UNII PQ6CK8PD0R - ASCORBIC ACID
|
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C05CX | Other capillary stabilizing agents | C Cardiovascular system → C05 Vasoprotectives → C05C Capillary stabilizing agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 60665905 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
